Eyecarrot Innovations Corp Stock Toronto S.E.
Equities
NAC
CA30233R1064
Advanced Medical Equipment & Technology
Sales 2021 | 728K 531K | Sales 2022 | 186K 136K | Capitalization | 3.73M 2.72M |
---|---|---|---|---|---|
Net income 2021 | -9M -6.57M | Net income 2022 | -16M -11.67M | EV / Sales 2021 | 22.7 x |
Net cash position 2021 | 42.79K 31.22K | Net Debt 2022 | 49.43K 36.06K | EV / Sales 2022 | 20.3 x |
P/E ratio 2021 |
-1.21
x | P/E ratio 2022 |
-0.16
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 94.06% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 22-01-04 |
Adrian Makuch
IRC | Investor Relations Contact | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Usama Chaudhry
BRD | Director/Board Member | 34 | 22-01-26 |
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 22-01-04 |
Mohsen Rahimi
BRD | Director/Board Member | - | 21-12-05 |
1st Jan change | Capi. | |
---|---|---|
-3.97% | 29.89B | |
+46.60% | 9.73B | |
+36.91% | 4.51B | |
-31.88% | 2.58B | |
-9.44% | 1.6B | |
-27.08% | 1.26B | |
+7.60% | 962M | |
-43.47% | 960M | |
-43.97% | 781M |